Sonida Senior Living, Inc. ( SNDA ) M&A Call November 5, 2025 9:00 AM EST Company Participants Jason Finkelstein Brandon Ribar - President, CEO & Director Conference Call Participants Ronald Kamdem - Morgan Stanley, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Presentation Operator Good morning. My name is Carrie, and I will be your conference operator today.

American International Group, Inc. ( AIG ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Quentin McMillan - VP, MD & Head of Investor Relations Peter Zaffino - CEO & Chairman Keith Walsh - Executive VP & CFO Jon Hancock - Executive VP and CEO of International Commercial Insurance & Global Personal Insurance Conference Call Participants Taylor Scott - Barclays Bank PLC, Research Division Brian Meredith - UBS Investment Bank, Research Division Meyer Shields - Keefe, Bruyette, & Woods, Inc., Research Division Michael Zaremski - BMO Capital Markets Equity Research Presentation Operator Good day, and welcome …

McDonald's Corporation ( MCD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Dexter Congbalay - Vice President of Investor Relations Christopher Kempczinski - Chairman President, & CEO Ian Borden - Executive VP & Global CFO Conference Call Participants David Palmer - Evercore ISI Institutional Equities, Research Division David Tarantino - Robert W. Baird & Co. Incorporated, Research Division Dennis Geiger - UBS Investment Bank, Research Division Gregory Francfort - Guggenheim Securities, LLC, Research Division Sara Senatore - BofA Securities, Research Division John Ivankoe - JPMorgan Chase & Co, Research Division Brian Bittner - Oppenheimer & …

Astec Industries, Inc. ( ASTE ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Stephen C. Anderson - Senior VP of Administration & Investor Relations Jaco van der Merwe - CEO, President & Director Brian Harris - Chief Financial Officer Conference Call Participants Steve Ferazani - Sidoti & Company, LLC Steven Ramsey - Thompson Research Group, LLC Presentation Operator Hello, and welcome to the Astec Industries Third Quarter 2025 Earnings Call.

Trimble Inc. ( TRMB ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Robert Painter - CEO, President & Director Phillip Sawarynski - Senior VP & CFO Conference Call Participants Jason Celino - KeyBanc Capital Markets Inc., Research Division Guy Drummond Hardwick - Barclays Bank PLC, Research Division Jonathan Ho - William Blair & Company L.L.C., Research Division Arsenije Matovic - Wolfe Research, LLC Nay Soe Naing - Joh.

Hippo Holdings Inc. ( HIPO ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Charles Sebaski - Head of Investor Relations Richard McCathron - President, CEO & Director Guy Zeltser - Chief Financial Officer Conference Call Participants Andrew Andersen - Jefferies LLC, Research Division Presentation Operator Hello, everyone. Thank you for attending today's Hippo Third Quarter 2025 Earnings Call.

Investors need to pay close attention to EW stock based on the movements in the options market lately.

IPGP posts strong Q3 results with higher sales in materials processing and medical applications, beating earnings and revenue estimates.

NVO's Q3 profit and revenues miss expectations as Wegovy and Ozempic growth slows amid U.S. compounding and pricing headwinds.

Bright Horizons Family (BFAM) remains a Hold as valuation reflects persistent core business challenges despite strong fundamentals in the Backup Care segment. Q3 2025 results highlight 26% year-over-year growth in Backup Care, but Full-Service revenue growth lags at 6% with thin margins. BFAM's Full-Service segment faces muted enrollment, weak pricing power, and macro risks from white-collar layoffs, limiting near-term upside.

Pfizer Inc. remains materially undervalued despite recent volatility, with its recovery momentum challenged by the ongoing Metsera bidding war. PFE's more stable guidance and robust pipeline offer multiple growth pathways, even if the Metsera acquisition turns out to be unsuccessful. The GLP-1 market's increasing competition and pricing pressures may weigh on PFE sentiment, but strong free cash flows and appealing dividend yield support a bullish view.

MELVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), today announced plans to host a business update conference call at 11:00 a.m. Eastern Time on Friday, November 14, 2025, to discuss the Company's sale of its CloudFirst subsidiary as well as its strategic business outlook.

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vera Bradley, Inc. (“Vera Bradley” or “the Company”) (NASDAQ: VRA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

WALL, N.J.--(BUSINESS WIRE)--The board of directors (the “Board”) of New Jersey Resources Corporation (NYSE: NJR) unanimously declared a quarterly dividend on its common stock of $0.475 per share. The dividend will be payable on January 2, 2026, to shareowners of record as of December 12, 2025. NJR has paid quarterly dividends continuously since its inception in 1952, and has raised the dividend every year for the last 30 years. About New Jersey Resources New Jersey Resources (NYSE: NJR) is a F.

UBER's third-quarter earnings and revenues surge past estimates, but soft EBITDA guidance and AV concerns drive shares lower.

Investors need to pay close attention to ESI stock based on the movements in the options market lately.

JKHY delivers 21% profit growth and lifts 2026 outlook after topping first-quarter revenues and earnings forecasts.

Novo Nordisk (NYSE:NVO) shares moved lower after the drugmaker posted weaker-than-expected revenue growth for Q3 and adjusted its full-year guidance, citing reduced growth expectations for its diabetes and obesity products amid increased competition and pricing pressure. Novo Nordisk downwardly revised its guidance, now expecting full-year 2025 sales growth of 8% to 11% at constant exchange rates (CER), down from its earlier guidance of 8% to 14%.

Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio pressured shares. Management aims to double Medicare Advantage margins by 2026, but faces headwinds from declining membership and regulatory changes.

Emerson Electric Co. ( EMR ) Q4 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Colleen Mettler - Vice President of Investor Relations Surendralal Karsanbhai - President, CEO & Director Michael Baughman - Executive VP, Chief Accounting Officer & CFO Ram Krishnan - Executive VP & COO Conference Call Participants Deane Dray - RBC Capital Markets, Research Division David Ridley-Lane - BofA Securities, Research Division Andrew Kaplowitz - Citigroup Inc., Research Division C. Stephen Tusa - JPMorgan Chase & Co, Research Division Julian Mitchell - Barclays Bank PLC, Research Division Nigel Coe - Wolfe Research, LLC Amit …